Email Us Here

Foundation Applauds FDA Approval of New Treatment Option for Patients With Thalassemia

The Cooley's Anemia Foundation applauds FDA approval of Ferriprox, Iron Chelator for people with Thalassemia. The Foundation believes a wider "menu" of treatment options is crucial for each individual patient to receive optimal treatment.